Clinical Trial

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to learn about the effects of biomarkertargeted therapy on ctDNA in patrticipants with CRC and MRD. This is an observational study. Participants will be monitored while receiving biomarker-directed therapy that is determined by your treating oncologist (cancer doctor) per standard of care, independent of this study.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-03-10; most recent amendment 2026-05-19.
Status change: Not Yet Recruiting → Recruiting 2025-11-06
Trial Details
NCT Number NCT06878131
Lead Sponsor M.D. Anderson Cancer Center
Conditions Colorectal Cancer
Enrollment 40 participants
Start Date 2025-04-18
Primary Completion 2026-12-22 (estimated)
Study Completion 2028-12-22 (estimated)
Updated on ClinicalTrials.gov 2026-05-22